Skip to main content
LEOCLAN Co.,Ltd. logo

LEOCLAN Co.,Ltd. — Investor Relations & Filings

Ticker · 7681 ISIN · JP3979320003 T Wholesale and retail trade
Open in API
Filings indexed 47 across all filing types
Latest filing 2024-02-14 Report Publication Anno…
Country JP Japan
Listing T 7681

About LEOCLAN Co.,Ltd.

https://www.leoclan.co.jp/

LEOCLAN Co.,Ltd. is a medical solutions provider that operates as a comprehensive partner for medical institutions. The company specializes in the wholesale, distribution, and repair of medical equipment, devices, and supplies. It offers a 'medical total solution' to meet diverse medical care, welfare, and health needs. This includes providing highly managed medical instruments and offering consulting services to support healthcare facility projects. The company leverages its experience to deliver integrated support, helping medical organizations navigate challenges and adapt to changes in the healthcare landscape.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is extremely short (645 characters) and contains a table structure typical of a Japanese regulatory filing cover page (提出書類: 確認書, 提出先: 近畿財務局長, 提出日: 2024年２月14日). The core content explicitly states that the company's President confirmed the appropriateness of the contents of the 'Quarterly Report' (四半期報告書) for the period ending December 31, 2023. This document is a confirmation statement regarding a periodic report, not the report itself. Since it is a confirmation/attestation related to a quarterly filing, it is most closely related to the comprehensive periodic report category. Given the options, the comprehensive report for a period shorter than a year is the Interim / Quarterly Report (IR). However, because this specific document is a 'Confirmation Document' (確認書) about the quarterly report's appropriateness, and not the full quarterly report (which would be classified as IR), it functions as a regulatory filing related to that period. Since there is no specific code for a 'Quarterly Report Confirmation,' and it is a formal regulatory submission, it falls under the general 'Regulatory Filings' (RNS) or potentially relates closely to the 'Interim / Quarterly Report' (IR). Given the context of confirming the 'Quarterly Report' (四半期報告書), IR is the most relevant underlying document type. However, following the 'MENU VS MEAL' rule, if this were an announcement *about* the IR, it would be RPA/RNS. This document *is* the confirmation required by law regarding the IR. In the context of Japanese filings, this type of confirmation document often accompanies the main filing. Since it is a specific regulatory submission confirming the accuracy of a periodic report, and not the report itself, RNS (Regulatory Filings) is the safest fallback for a specific confirmation document that isn't the main report (IR). If the document were the full quarterly report, it would be IR. Since it is the confirmation, RNS is appropriate as a specific regulatory submission.
2024-02-14 Japanese
四半期報告書－第24期第1四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet and income statement for the first quarter of the 24th fiscal period (October 1, 2023, to December 31, 2023). It includes management analysis, stock information, and audit confirmation, which fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-02-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kinki Local Finance Bureau Director on December 22, 2023. Section 1 explicitly states the reason for filing is that resolutions were passed at the Extraordinary General Meeting (EGM) held on December 21, 2023, pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. Section 2 details the resolutions, specifically concerning the 'Resolution on Appropriation of Surplus' (剰余金の処分の件), including the dividend amount (50 yen per share) and the voting results (99.99% approval). This structure—reporting the results of a shareholder meeting resolution (specifically dividend approval) via an official filing—aligns perfectly with the purpose of reporting voting outcomes from a general meeting. While it contains dividend information (DIV), the primary focus and regulatory context is the official declaration of the voting results from the meeting. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-12-22 Japanese
内部統制報告書－第23期(2022/10/01－2023/09/30)
Governance Information Classification · 100% confidence The document explicitly states in the header section (【提出書類】) that it is an "内部統制報告書" (Internal Control Report). It references the legal basis under the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項) and details the scope, criteria, and procedures for evaluating internal controls over financial reporting, concluding that the internal controls are effective as of the end of the business year (2023年９月30日). This content aligns perfectly with the description of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although this specific document focuses on internal controls over financial reporting, which is a key component often covered under this broader category or related to the 10-K but presented separately here. Given the specific focus on the 'Internal Control Report' (内部統制報告書) and the structure, it is best classified as AR, as it is a standalone report on internal controls rather than the full Annual Report (10-K) or a mere announcement (RPA).
2023-12-21 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is extremely short (643 characters) and contains a header section titled "【提出書類】 確認書" (Document Submitted: Confirmation Document) and references the Financial Instruments and Exchange Act (金融商品取引法). Section 1 explicitly states that the Representative Director confirmed that the contents of the company's 'Annual Securities Report' (有価証券報告書) for the 23rd period (ending September 30, 2023) are appropriate according to financial instruments laws. This document is a confirmation statement regarding the accuracy of the Annual Securities Report (which corresponds to a 10-K filing in the US context), not the full report itself. Since it is a specific confirmation document related to the annual filing, and not a general announcement of publication (RPA) or a general regulatory filing (RNS), it most closely aligns with the Audit Report/Information category (AR) as it pertains to the verification/attestation of the annual results, or potentially a specific regulatory confirmation document. Given the options, 'AR' covers standalone audit reports and applied accounting principles/results verification, making it the best fit for a formal confirmation of the annual filing's accuracy, distinct from the 10-K itself.
2023-12-21 Japanese
有価証券報告書－第23期(2022/10/01－2023/09/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. The header explicitly identifies it as a '有価証券報告書' (Securities Report) filed under the Financial Instruments and Exchange Act, covering the fiscal year from October 1, 2022, to September 30, 2023. It contains extensive XBRL tagging and financial data, confirming it is the full annual report rather than an announcement. FY 2023
2023-12-21 Japanese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.